By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Emiliem, Inc. 

6027 Christie Avenue
Emeryville  California  94608-1903  U.S.A.
Phone: 510-923-0404 Fax: 866-803-8811



Drug Discovery

Company News
Emiliem, Inc. and National Institutes of Health (NIH) Sign CRADA for Clinical Development of Novel mTOR Inhibitors 8/5/2008 9:18:21 AM
Emiliem, Inc. Expands Management Team With Industry Veterans Donna Romero and Diane Beuving 5/7/2008 9:04:10 AM
Company Profile for Emiliem, Inc. 5/2/2008 9:15:17 AM
Emiliem, Inc. Acquires World-Wide Rights to Develop and Commercialize a Novel Treatment for Cancer and Other Proliferative and Inflammatory Diseases 4/23/2008 6:46:06 AM
The Van Andel Research Institute and Emiliem, Inc. Sign Major Translational Medicine and Biomarker Agreement 5/4/2007 1:17:02 PM
Invitrogen Corporation (IVGN) and Emiliem, Inc. Sign Major Kinase Screening Agreement 3/29/2007 12:19:50 PM
Emiliem, Inc. And MIR Preclinical Services Sign Cancer Pharmacology Agreement 1/12/2007 10:24:52 AM
Emiliem, Inc. Release: Edwin P. Ching, J.D., Ph.D., VP Intellectual Property To Present Workshop On Intellectual Property And Critical Paths 9/26/2006 1:41:49 PM
Three Industry Scientists, Bahija Jallal, Manoj Desai, And Sean Ekins, Named To Emiliem, Inc.'s Scientific Advisory Board 9/15/2006 7:19:18 PM